Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer

被引：20
|
作者：
Abbosh, Philip H. [1 ,2 ]
Plimack, Elizabeth R. [3 ]
机构：
[1] Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Einstein Med Ctr, Dept Urol, Philadelphia, PA USA
[3] Fox Chase Canc Ctr, Dept Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
BLADDER CANCER | 2018年 / 4卷 / 01期
关键词：
DNA damage response; DNA damage repair; cisplatin; immunotherapy; chemoresponse; bladder cancer; upper tract urothelial carcinoma; NONPOLYPOSIS COLORECTAL-CANCER; SOMATIC ERCC2 MUTATIONS; MISMATCH-REPAIR; GENOMIC CHARACTERIZATION; XERODERMA-PIGMENTOSUM; PD-1; BLOCKADE; CISPLATIN; IDENTIFICATION; SENSITIVITY; TRICHOTHIODYSTROPHY;
D O I：
10.3233/BLC-170129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DNA damage response and repair genes (DDR genes) are commonly mutated in bladder cancer. The biological impact of these mutations is an area of intense basic, translational, and clinical interest. As next generation sequencing increases its foothold in the treatment of localized and advanced bladder cancer, the role of DDR genes will continue to evolve. We review the inventory and biology of DDR genes in bladder cancer and describe known and candidate roles for loss of DDR genes to engender therapeutic susceptibilities to various anti-cancer agents.
引用
收藏
页码：9 / 18
页数：10
相关论文
共 50 条
  • [1] Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer
    Wojtczyk-Miaskowska, Anita
    Presler, Malgorzata
    Michajlowski, Jerzy
    Matuszewski, Marcin
    Schlichtholz, Beata
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (06) : 2404 - 2417
  • [2] Platinum Resistance in Ovarian Cancer: Role of DNA Repair
    Damia, Giovanna
    Broggini, Massimo
    CANCERS, 2019, 11 (01)
  • [3] The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
    Gao, Dan
    Herman, James G.
    Guo, Mingzhou
    ONCOTARGET, 2016, 7 (24) : 37331 - 37346
  • [4] Clinical significance and immune landscape of angiogenesis-related genes in bladder cancer
    Liu, Gang
    Zhang, Tingting
    Gui, Dingwen
    Liu, Qin
    AGING-US, 2023, 15 (22): : 13118 - 13133
  • [5] Clinical implications of molecular subtyping in bladder cancer
    Satyal, Uttam
    Sikder, Rahmat K.
    McConkey, David
    Plimack, Elizabeth R.
    Abbosh, Philip H.
    CURRENT OPINION IN UROLOGY, 2019, 29 (04) : 350 - 356
  • [6] Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerations
    Ganzinelli, M.
    Mariani, P.
    Cattaneo, D.
    Fossati, R.
    Fruscio, R.
    Corso, S.
    Ricci, F.
    Broggini, M.
    Damia, G.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (07) : 1086 - 1094
  • [7] Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer
    Black, Peter C.
    Brown, Gordon A.
    Dinney, Colin P. N.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (07) : 1015 - 1026
  • [8] Impact of DNA Repair Deficiency in the Evolving Treatment Landscape of Bladder Cancer
    D'Andrea, Vincent D.
    Magnani, Christopher J.
    Ernandez, John
    Bellmunt, Joaquim
    Mossanen, Matthew
    Clinton, Timothy N.
    Carvalho, Filipe L. F.
    Mouw, Kent W.
    CURRENT UROLOGY REPORTS, 2025, 26 (01)
  • [9] Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
    Li, Tianhang
    Jiang, Ning
    Bai, Yuhao
    Liu, Tianyao
    Zhao, Zihan
    Xu, Xinyan
    Zhang, Yulin
    Wei, Fayun
    Sun, Rui
    Liu, Siyang
    Li, Jiazheng
    Guo, Hongqian
    Yang, Rong
    HELIYON, 2023, 9 (03)
  • [10] Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer
    Yang, Yong
    Yu, Jieqing
    Xiong, Yuanping
    Xiao, Jiansheng
    Dai, Daofeng
    Zhang, Feng
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
12345